NASDAQ:GBNH

Greenbrook TMS (GBNH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.04
$0.10
50-Day Range
$0.05
$0.38
52-Week Range
$0.10
$1.82
Volume
787,000 shs
Average Volume
3.60 million shs
Market Capitalization
$1.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GBNH stock logo

About Greenbrook TMS Stock (NASDAQ:GBNH)

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

GBNH Stock News Headlines

Greenbrook TMS Inc. Announces Delisting From Nasdaq
Greenbrook TMS to delist shares from Nasdaq
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ
Greenbrook TMS Stock (NASDAQ:GBNH) Insider Trades
Why Is Greenbrook TMS (GBNH) Stock Up 174% Today?
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING
Greenbrook TMS Amends Credit Agreement, Discloses Update
Greenbrook TMS Secures Additional Senior Secured Loans
Greenbrook TMS raises $4M in debt financing
GREENBROOK TMS RAISES US$4.0 MILLION IN DEBT FINANCING
GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING
GREENBROOK TMS RAISES US$2.0 MILLION IN DEBT FINANCING
GREENBROOK APPOINTS INTERIM CHIEF FINANCIAL OFFICER
See More Headlines
Receive GBNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Greenbrook TMS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/14/2023
Today
4/26/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:GBNH
Fax
N/A
Employees
492
Year Founded
N/A

Profitability

Net Income
$-61,730,000.00
Pretax Margin
-83.55%

Debt

Sales & Book Value

Annual Sales
$69.10 million
Book Value
($1.72) per share

Miscellaneous

Free Float
31,959,000
Market Cap
$1.96 million
Optionable
Not Optionable
Beta
2.19
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Sasha Cucuz (Age 45)
    Executive Chairman
  • Mr. William P. Leonard (Age 59)
    President, CEO & Director
    Comp: $468.75k
  • Dr. Geoffrey Grammer M.D. (Age 53)
    Chief Medical Officer
    Comp: $293.75k
  • Mr. Peter Willett
    Chief Financial Officer
  • Glen Akselrod
    Investor Relations Officer
  • Ms. Iris Krug
    VP of Compliance & Privacy Officer
  • Ms. Brittany Schwemmer
    Vice President of Human Resources

GBNH Stock Analysis - Frequently Asked Questions

Should I buy or sell Greenbrook TMS stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Greenbrook TMS in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GBNH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GBNH, but not buy additional shares or sell existing shares.
View GBNH analyst ratings
or view top-rated stocks.

How were Greenbrook TMS's earnings last quarter?

Greenbrook TMS Inc. (NASDAQ:GBNH) released its quarterly earnings data on Monday, August, 14th. The company reported ($0.30) earnings per share for the quarter, missing analysts' consensus estimates of ($0.29) by $0.01. The firm had revenue of $18.35 million for the quarter, compared to the consensus estimate of $19.15 million. During the same quarter in the previous year, the business earned ($0.41) earnings per share.

This page (NASDAQ:GBNH) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners